Additionally, using the PRISM screening portal [33], pronounced sensitivity to the HMGCR inhibitors lovastatin and simvastatin was found in some tumors, including RMS, melanoma, Ewing Sarcoma, hepatocellular carcinoma, and diffuse glioma (Figure 1E). The gene discussed is HMGCR; the disease is hepatocellular carcinoma.